ID: MRFR/LS/4043-HCR | 110 Pages | Author: Rahul Gotadki | May 2023
Blood Pressure Test Market Synopsis
Blood pressure test market is expected to reach USD 1562 Million by 2030 at 5.6% CAGR during the forecast period 2022-2030.Blood pressure is a measure of the amount of blood pushed against the walls of the arteries. It is namely of two types; systolic pressure and diastolic pressure and is measured in millimeters of mercury (mm Hg). Blood pressure test usually is done to diagnose hypertension, one of the major risk factor for coronary heart disease. It can be done at hospitals, clinics, and diagnostic centers, to determine the elevation in the blood pressure in case of an emergency. Blood pressure test can also be done at home with numerous blood pressure testing devices available in the market.
The blood pressure test market is driven by rising prevalence of chronic diseases such as cardiovascular diseases, hypertension, diabetes, and others. Furthermore, changing lifestyle, and increasing demand for diagnostic devices for cardiovascular diseases is facilitating the market growth. However, a limited number of trained personnel has restrained the growth of the market. However, the high cost of diagnosis and treatment of cardiovascular diseases restrains the growth of the market.
According to the WHO, about 59% of the mortality is due to chronic diseases, and almost 35 million people die of chronic diseases in the world. Cardiovascular diseases and diabetes are increasing the economic burden of various developing and developed nations across the globe.
FIGURE 1: Global Blood Pressure Test Market by Type, 2016 (%)
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
The blood pressure test market is segmented on the basis of product, indication, and end user.
On the basis of the product, the blood pressure test market is segmented into sphygmomanometers, blood pressure transducers, blood pressure instrument accessories, and others.
Sphygmomanometers is further segmented into mercury, aneroid and digital. Blood pressure transducers is further segmented into disposable and reusable. Blood pressure instrument accessories is further segmented into blood pressure cuffs, bladders, and bulbs & valve.
On the basis of indication, the blood pressure test market is segmented into hypertension, coronary heart disease, and others.
On the basis of the end user, the blood pressure test market is segmented into hospitals & clinics, diagnostic centers, home care and others.
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Regional Analysis of the Blood Pressure Test Market
The Americas account for the largest blood pressure test market. Increasing prevalence of cardiovascular diseases and diabetes is the major driving factor for the growth of the market. According to the Center for Diseases Control and Prevention (CDC), 9.3% of the total American population is suffering from diabetes. Increasing number of diabetic and obese population, rising demand for better treatment for the diseases and well-developed infrastructure has provided fuel for the growth of the market. North America accounts for the major share in the America advanced blood pressure test market.
Europe accounts for the second largest market due to the well-developed healthcare sector, continuously increasing patient population, and high healthcare expenditure. Additionally, increasing prevalence of diabetes in the European Union (EU) also fuels the market growth. Germany, the U.K., and France hold the first, second and third position in the market.
Asia Pacific is expecting the fastest growth for this market. Increasing prevalence of cardiovascular diseases and rising geriatric population are the major driving factor for the growth of the market. India and China are the two major regions with the highest contribution to the market growth owing to highest diabetic population and increasing the presence of heart attack among these patients. Additionally, rising geriatric population further drive the growth of the market. Furthermore, rapid development of the healthcare infrastructure also accelerates the market growth. According to the International diabetic federation, India and China account 180 million people have diabetes which is approximately 40% of world’s diabetic population. The rising prevalence of diabetes in this region is attributed to rising prevalence of lifestyle disorders such as obesity, and addiction such as smoking. According to the International Diabetes Foundation, 98.4 million and 65.1 million diabetic population live in China and India respectively.
In the Middle East & Africa, the market is expected to show steady growth due to developing healthcare system, and increasing demand for diagnostic and treatment services. The Middle East is the major contributor to the market which is driven by the presence of well-developed economies such as Kuwait and Qatar. Whereas, Africa exhibits slow growth due to limited development in the field of medical science and presence of poor economic conditions in various developing regions of Africa.
Key Players in the Blood Pressure Test Market
Some of the key players in blood pressure test market are OMRON Corporation, SunTech Medical, Inc., SPENGLER, Koninklijke Philips N.V., Schiller AG, Spacelabs Healthcare, American Diagnostic Corporation, Bosch + Sohn GmbH u. Co. KG, Withings SA, Welch Allyn, Inc. (Hill-Rom), A&D Medical, and General Electric Company.
|Market Size||2030: USD 1562 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, Indication, and End user|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||OMRON Corporation, SunTech Medical, Inc., SPENGLER, Koninklijke Philips N.V., Schiller AG, Spacelabs Healthcare, American Diagnostic Corporation, Bosch + Sohn GmbH u. Co. KG, Withings SA, Welch Allyn, Inc. (Hill-Rom), A&D Medical, and General Electric Company|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||
blood pressure test market is projected to grow at a 5.6% CAGR between 2022-2030.
The Americas is expected to dominate the blood pressure test market.
Major end users of blood pressure test market include home care, diagnostic centers, hospitals and clinics, and others.
Key factors driving the blood pressure test market growth include rising prevalence of diabetes and changing lifestyle.
High cost of diagnosis and treatment may limit the blood pressure test market growth.
Key Questions Answered
Why Choose Market Research Future?